Array BioPharma, a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer, announced it has appointed Jason Haddock as chief financial officer. Mr. Haddock replaces David Horin, who had been acting as Array’s interim chief financial officer. Mr. Haddock has more than 15 years of financial and operational experience in the biopharmaceutical industry. He held leadership positions of inc...